Oddoneout, people are correct in saying we won't see $6 per share, unless we are talking many years in the future with a proven and successful drug/treatment and IMU going it alone. It's more likely that there will be a buy out or even a licensing arrangement (my preference)
Some Big Pharma's are worth massive amounts compared to Australian companies there's obviously big money in drugs, for those interested GSK is way down the list at around 70 Billion Market Cap, so may be difficult for them to compete against the likes of Proctor & Gamble or Roche in bidding for a keenly sought after drug/treatment.
Imugene's Leslie Chong says positive HER-Vaxx data 'validates entire platform', page-244
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.2¢ |
Change
-0.001(1.89%) |
Mkt cap ! $382.1M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.4¢ | 5.2¢ | $216.1K | 4.106M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 1854997 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 382882 | 4 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |